The Enterprise Value as of November 2024 (TTM) for Legend Biotech Corporation (LEGN) is 7.40B

According to Legend Biotech Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 7.40B. This represents a change of 4.65% compared to the average of 7.07B of the last 4 quarters.

Legend Biotech Corporation (LEGN) Historical Enterprise Value (quarterly & annually)

How has LEGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Legend Biotech Corporation over the last ten years is 5.59B. The current 7.40B Enterprise Value has changed 13.13% with respect to the historical average. Over the past ten years (40 quarters), LEGN's Enterprise Value was at its highest in in the November 2022 quarter at 15.35B. The Enterprise Value was at its lowest in in the September 2024 quarter at -112686000.00.

Legend Biotech Corporation (LEGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Legend Biotech Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Legend Biotech Corporation (LEGN) Average Enterprise Value

How has LEGN Enterprise Value performed in the past?

The current Enterprise Value of Legend Biotech Corporation (LEGN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Legend Biotech Corporation (LEGN) Enterprise Value vs. Peers

How is LEGN’s Enterprise Value compared to its peers?

Legend Biotech Corporation’s Enterprise Value is less than Vaxcyte, Inc. (10.01B), greater than Apellis Pharmaceuticals, Inc. (3.90B), greater than Travere Therapeutics, Inc. (1.95B), greater than Akero Therapeutics, Inc. (2.00B), greater than IVERIC bio, Inc. (5.13B), greater than Blueprint Medicines Corporation (6.36B), greater than Amylyx Pharmaceuticals, Inc. (291.98M), less than Karuna Therapeutics, Inc. (12.43B), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than Zai Lab Limited (2.48B), less than Seagen Inc. (42.84B), less than Alnylam Pharmaceuticals, Inc. (31.79B), less than Ascendis Pharma A/S (7.61B), greater than 89bio, Inc. (940.63M), less than Madrigal Pharmaceuticals, Inc. (7.46B), greater than Pliant Therapeutics, Inc. (770.48M), greater than Arcellx, Inc. (4.79B), greater than Stoke Therapeutics, Inc. (457.69M), greater than Mirati Therapeutics, Inc. (3.91B), greater than Terns Pharmaceuticals, Inc. (222.97M),

Build a custom stock screener for Legend Biotech Corporation (LEGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Legend Biotech Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Legend Biotech Corporation (LEGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Legend Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.